Lexston Mining Corporation Announces Fieldwork on Dory Property and two Marketing Agreements Biotech Investing
Republic Technologies Inc. Announces Up to US$100 Million Proposed Secured Convertible Note Facility Financing Medical Device Investing
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director Biotech Investing
Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum Biotech Investing
Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities Biotech Investing
BioAtla Presents Promising Interim Data from its Phase 1 Trial with BA3182 in Patients with Treatment Refractory Metastatic Adenocarcinoma at ESMO 2025 Biotech Investing
Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders Biotech Investing
Covalon to Participate in the Planet MicroCap Showcase: TORONTO on October 22, 2025 Biotech Investing
Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases
Nextech3D.ai Reports Strong 20% Q2 Sequential Revenue Growth With Gross Margins of 88% For the Three Months Ended September 30, 2025 ("Q2 2026")
